Cargando…
Effects of levetiracetam and oxcarbazepine monotherapy on intellectual and cognitive development in children with benign epilepsy with centrotemporal spikes
Levetiracetam (LEV) and oxcarbazepine (OXC) are commonly used in the treatment of epilepsy, but their efficacy and safety have seldom been compared for the treatment of children with benign epilepsy with centrotemporal spikes (BECTS). We thus assessed the efficacy of LEV and OXC monotherapy in the t...
Autores principales: | Suo, Gui-hai, Zheng, Yu-qin, Wu, You-jia, Tang, Ji-hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443489/ https://www.ncbi.nlm.nih.gov/pubmed/33590471 http://dx.doi.org/10.1007/s13760-021-01613-5 |
Ejemplares similares
-
Oxcarbazepine monotherapy in children with benign epilepsy with centrotemporal spikes improves quality of life
por: Liu, Wan-Ting, et al.
Publicado: (2020) -
Is ″benign Childhood Epilepsy with Centrotemporal Spikes″ Always Benign?
por: SAEED, Muhammad, et al.
Publicado: (2014) -
Antiepileptic Drug of Levetiracetam Decreases Centrotemporal Spike-Associated Activation in Rolandic Epilepsy
por: Zhang, Qirui, et al.
Publicado: (2018) -
The relationship between epilepsy and cognitive function in benign childhood epilepsy with centrotemporal spikes
por: Li, Yihan, et al.
Publicado: (2020) -
Benign Childhood Epilepsy with Centrotemporal Spikes: To Treat or Not to Treat
por: Kwon, Soonhak, et al.
Publicado: (2013)